Cargando…
Alanylglutamine Relieved Asthma Symptoms by Regulating Gut Microbiota and the Derived Metabolites in Mice
OBJECTIVE: Allergic asthma is a chronic inflammatory disease, which seriously affects the life quality of patients, especially children. Alanylglutamine is a nutritional supplement with potential protective and anti-inflammatory effects, but its function in allergic asthma remains elusive. In this s...
Autores principales: | Liu, Shao-Kun, Ma, Li-Bing, Yuan, Yu, Ji, Xiao-Ying, Sun, Wen-Jin, Duan, Jia-Xi, Zeng, Qing-Ping, Wasti, Binaya, Xiao, Bing, Zheng, Jian-Fei, Chen, Ping, Xiang, Xu-Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785351/ https://www.ncbi.nlm.nih.gov/pubmed/33456673 http://dx.doi.org/10.1155/2020/7101407 |
Ejemplares similares
-
Role of Epigenetics in the Pathogenesis, Treatment, Prediction, and Cellular Transformation of Asthma
por: Wasti, Binaya, et al.
Publicado: (2021) -
Role of Sex Hormones at Different Physiobiological Conditions and Therapeutic Potential in MBD2 Mediated Severe Asthma
por: Wasti, Binaya, et al.
Publicado: (2021) -
Targeting the Gut Microbiota to Relieve the Symptoms of Irritable Bowel Syndrome
por: Wollny, Tomasz, et al.
Publicado: (2021) -
Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study
por: Li, Ning, et al.
Publicado: (2021) -
Corrigendum: Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study
por: Li, Ning, et al.
Publicado: (2021)